Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5926 AL 5940

Differential diagnosis of Alzheimer's disease using spectrochemical analysis of blood

Paraskevaidi M, Morais CLM, Lima KMG, Snowden JS, Saxon JA, Richardson AMT, Jones M, Mann DMA, Allsop D, Martin-Hirsch PL, Martin FL.

Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):E7929-E7938. doi: 10.1073/pnas.1701517114. Epub 2017 Sep 5.

[Memantine: from the original brand to generics]

Titova NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):136-143. doi: 10.17116/jnevro2017117101136-143.

Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease

Liu CY, Ohki Y, Tomita T, Osawa S, Reed BR, Jagust W, Van Berlo V, Jin LW, Chui HC, Coppola G, Ringman JM.

J Alzheimers Dis. 2017;58(4):1035-1041. doi: 10.3233/JAD-161203.

Signs and symptoms preceding the diagnosis of Alzheimer's disease: a systematic scoping review of literature from 1937 to 2016

Bature F, Guinn BA, Pang D, Pappas Y.

BMJ Open. 2017 Aug 28;7(8):e015746. doi: 10.1136/bmjopen-2016-015746.

Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome

Zis P, Strydom A.

Free Radic Biol Med. 2018 Jan;114:3-9. doi: 10.1016/j.freeradbiomed.2017.08.024. Epub 2017 Sep 1.

7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature

McKiernan EF, O'Brien JT.

J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):564-574. doi: 10.1136/jnnp-2016-315022. Epub 2017 Mar 4.

Ultra-Early Phase pathologies of Alzheimer's disease and other neurodegenerative diseases

Okazawa H.

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(6):361-377. doi: 10.2183/pjab.93.022.

Point-of-Care Devices Using Disease Biomarkers To Diagnose Neurodegenerative Disorders

Wei TY, Fu Y, Chang KH, Lin KJ, Lu YJ, Cheng CM.

Trends Biotechnol. 2018 Mar;36(3):290-303. doi: 10.1016/j.tibtech.2017.11.004. Epub 2017 Dec 11.

miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease

Mushtaq G, Greig NH, Anwar F, Zamzami MA, Choudhry H, Shaik MM, Tamargo IA, Kamal MA.

Med Chem. 2016;12(3):217-25. doi: 10.2174/1573406411666151030112140.

Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins

Butterfield DA, Palmieri EM, Castegna A.

Expert Rev Proteomics. 2016;13(3):259-74. doi: 10.1586/14789450.2016.1149470.

Protein Amyloidogenesis Investigated by Small Angle Scattering

Ricci C, Spinozzi F, Mariani P, Ortore MG.

Curr Pharm Des. 2016;22(26):3937-49. doi: 10.2174/1381612822666160519113237.

Cognitive interventions in Alzheimer's and Parkinson's diseases: emerging mechanisms and role of imaging

Vemuri P, Fields J, Peter J, Klöppel S.

Curr Opin Neurol. 2016 Aug;29(4):405-11. doi: 10.1097/WCO.0000000000000346.

Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases

Parnetti L, Eusebi P, Lleó A.

Front Neurol Neurosci. 2016;39:117-23. doi: 10.1159/000445452. Epub 2016 Jul 26.

The Significance of the Default Mode Network (DMN) in Neurological and Neuropsychiatric Disorders: A Review

Mohan A, Roberto AJ, Mohan A, Lorenzo A, Jones K, Carney MJ, Liogier-Weyback L, Hwang S, Lapidus KA.

Yale J Biol Med. 2016 Mar 24;89(1):49-57. eCollection 2016 Mar.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias